Table 4.
PM2.5 per 5 ug/m3 | PM2.5 ≥12 ug/m3 | |||||||
---|---|---|---|---|---|---|---|---|
5 years post-diagnosis | 10 years post-diagnosis | 5 years post-diagnosis | 10 years post-diagnosis | |||||
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |
Cancer mortality | ||||||||
Breast | 1.18 | 0.91–1.54 | 1.16 | 0.97–1.39 | 1.50a | 1.29–1.74 | 1.30a | 1.13–1.50 |
Cervical | 0.84 | 0.62–1.13 | 0.83 | 0.67–1.02 | 0.83 | 0.61–1.13 | 0.78 | 0.57–1.06 |
Colorectal | 1.36a | 1.06–1.75 | 1.23a | 1.00–1.52 | 1.74a | 1.29–2.35 | 1.67a | 1.20–2.31 |
Kidney and renal pelvis | 4.06a | 2.06–7.99b | 6.95a | 3.10–15.59b | -- | -- | ||
Lung | 0.94 | 0.68–1.29 | 0.86 | 0.59–1.26 | -- | -- | ||
Testicular | 0.92 | 0.54–1.58b | 0.88 | 0.54–1.42b | -- | -- | ||
Thyroid | -- | 1.16 | 0.61–2.19b | -- | -- | |||
Other | 1.09 | 0.98–1.22 | 1.05 | 0.94–1.19 | 1.03 | 0.88–1.20 | 1.00 | 0.84–1.18 |
All-cause mortality | ||||||||
Breast | 1.26 | 0.98–1.62 | 1.20 | 0.99–1.45 | 1.62a | 1.42–1.84 | 1.36a | 1.19–1.55 |
Cervical | 0.86 | 0.74–1.01 | 0.83a | 0.76–0.90 | 0.85 | 0.62–1.18 | 0.73a | 0.54–0.99 |
Colorectal | 1.31a | 1.04–1.66 | 1.21 | 0.99–1.49 | 1.65a | 1.35–2.03 | 1.64a | 1.31–2.04 |
Kidney and renal pelvis | 2.86a | 2.09–3.91 | 2.09a | 1.16–3.79b | -- | -- | ||
Lung | 1.02 | 0.77–1.34 | 0.93 | 0.67–1.29 | -- | -- | ||
Testicular | 0.99 | 0.58–1.70b | 0.95 | 0.62–1.46 | -- | -- | ||
Thyroid | -- | 1.28 | 0.74–2.23b | -- | -- | |||
Other | 1.07 | 0.98–1.18 | 1.04 | 0.94–1.15 | 1.01 | 0.84–1.21 | 0.99 | 0.82–1.19 |
HR=hazard ratio; 95% CI=95% confidence interval; Cumulative average monthly PM2.5 over all residential ZIP codes over 5 and 10 years; Models adjusted for sex, race/ethnicity, age at diagnosis, and census tract SES at diagnosis clustered by county; Separate baseline hazard included for stage of diagnosis; Estimates rounded to the nearest hundredth;
Hazard ratios significant if null value not included in the 95% CI;
Ratio of upper-to-lower 95% confidence interval is ≥3;
Event count <10.